A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: analysis of risk factors for clinical outcome. (Q54171000)
Jump to navigation
Jump to search
scientific article published in June 1995
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: analysis of risk factors for clinical outcome. |
scientific article published in June 1995 |
Statements
A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: analysis of risk factors for clinical outcome. (English)
Stiff P
Bayer R
Camarda M
Tan S
Dolan J
Potkul R
Loutfi S
Kinch L
Sosman J
Peace D
1 June 1995
57
3
278-285